Delivery Order SPE2DB22D1017-SPE2DB25FF3PD

Award Date 1/21/25
Potential Completion Date 2/11/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,329.89, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ORGOVYX 120 MG TABLET, a prescription medication, to support U.S. military and federal healthcare programs. The contract is a Firm Fixed Price Delivery Order that runs through September 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $1,385.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ORGOVYX 120 MG TABLET UU 30S, a pharmaceutical product, and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,375.85, is a delivery order for the supply of ORGOVYX 120 MG TABLET medication. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ORGOVYX 120 MG Tablets. The $4,127.55 firm fixed-price contract has an ultimate completion date of January 2, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,771.04, is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which is valued at $999,999,999 and runs through November 2026. The contract is for the delivery of ORGOVYX 120 MG TABLET, a pharmaceutical product, to support...
This federal contract award, valued at $1,385.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ORGOVYX 120 MG TABLET UU 30S, a pharmaceutical product, to support federal healthcare programs. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,313.12 firm fixed-price delivery order contract is for the supply of ORGOVYX 120 MG TABLET medication, with a completion date of February 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $3,989.67, is for the delivery of ORGOVYX 120 MG TABLET UU 30S, a prescription medication. The contract has a period of performance through May 22, 2024 and is structured as a Firm Fixed Price Delivery Order. Additionally, AmerisourceBergen holds a $999,999,999.00 Indefinite...
This federal contract award, valued at $1,375.85, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ORGOVYX 120 MG TABLET, a specialty medication, with an ultimate completion date of January 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.52 firm fixed-price delivery order is for the drug ORGOVYX 120 MG TABLET, with a completion date of February 21, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF3PD
    Delivery Order

This federal contract award, valued at $1,385.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ORGOVYX 120 MG TABLET UU 30S, a pharmaceutical product.

The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and there are no major subcontractors mentioned. The DLA is the funding agency, which is responsible for providing medical products and services to the U.S. military and other federal agencies.

Generated 4/22/25, 11:57 AM